Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Chan

Showing results (261-270 of 271) with videos related to

Pageof 28
Sort By:
Cancer Cell|June 4, 2026
Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinomaLynda Vuong, Andrew E Cornish, Jennifer Pfeil, et al.
Nature Communications|February 25, 2016
FAT1 mutations cause a glomerulotubular nephropathyHeon Yung Gee, Carolin E Sadowski, Pardeep K Aggarwal, et al.
Journal of the National Cancer Institute|January 11, 2021
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC TrialNadeem Riaz, Eric Sherman, Xin Pei, et al.
Nature Communications|November 25, 2021
Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insightsOlusegun Isaac Alatise, Gregory C Knapp, Avinash Sharma, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Platelets regulate glioblastoma growth and immunity via sex-dependent PAR4 - Estrogen receptor beta signalingAnthony R Sloan, George Bukenya, Gavin P Tannish, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2019
Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized GliomasPhilip Jonsson, Andrew L Lin, Robert J Young, et al.
Nature Communications|December 23, 2022
Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiationJoshua I Warrick, Wenhuo Hu, Hironobu Yamashita, et al.
Nature Communications|November 3, 2022
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiationJoshua I Warrick, Wenhuo Hu, Hironobu Yamashita, et al.
Journal for Immunotherapy of Cancer|March 27, 2020
Consensus guidelines for the definition, detection and interpretation of immunogenic cell deathLorenzo Galluzzi, Ilio Vitale, Sarah Warren, et al.
Nature Genetics|January 16, 2019
Tumor mutational load predicts survival after immunotherapy across multiple cancer typesRobert M Samstein, Chung-Han Lee, Alexander N Shoushtari, et al.
Pageof 28

Showing results (261-270 of 271) with videos related to

Sort By:
Pageof 28
Cancer Cell|June 4, 2026
Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinomaLynda Vuong, Andrew E Cornish, Jennifer Pfeil, et al.
Nature Communications|February 25, 2016
FAT1 mutations cause a glomerulotubular nephropathyHeon Yung Gee, Carolin E Sadowski, Pardeep K Aggarwal, et al.
Journal of the National Cancer Institute|January 11, 2021
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC TrialNadeem Riaz, Eric Sherman, Xin Pei, et al.
Nature Communications|November 25, 2021
Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insightsOlusegun Isaac Alatise, Gregory C Knapp, Avinash Sharma, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Platelets regulate glioblastoma growth and immunity via sex-dependent PAR4 - Estrogen receptor beta signalingAnthony R Sloan, George Bukenya, Gavin P Tannish, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2019
Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized GliomasPhilip Jonsson, Andrew L Lin, Robert J Young, et al.
Nature Communications|December 23, 2022
Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiationJoshua I Warrick, Wenhuo Hu, Hironobu Yamashita, et al.
Nature Communications|November 3, 2022
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiationJoshua I Warrick, Wenhuo Hu, Hironobu Yamashita, et al.
Journal for Immunotherapy of Cancer|March 27, 2020
Consensus guidelines for the definition, detection and interpretation of immunogenic cell deathLorenzo Galluzzi, Ilio Vitale, Sarah Warren, et al.
Nature Genetics|January 16, 2019
Tumor mutational load predicts survival after immunotherapy across multiple cancer typesRobert M Samstein, Chung-Han Lee, Alexander N Shoushtari, et al.
Pageof 28